3Dimensions™

Mammography System

The fastest, highest resolution

breast tomosynthesis system ever.
The 3Dimensions™ Mammography System matches
the unrivaled performance of our 3D Mammography™
exam, which is more accurate than conventional 2D
mammograms, detecting up to 65% more invasive breast
cancers.§ Breakthrough improvements transform
the patient experience without compromising speed
or accuracy.

Designed to improve
visibility of fine details
for greater diagnostic
confidence.*

Providing the same clinical

performance faster by
accelerating reading time to
streamline workflow.**

Improve the patient experience

with curved compression
surface that mirror the shape
of the breast, for a more even
compression.
SHARPER
SMARTER
SIMPLER
A better 3D™ breast screening
experience – for everyone.
The 3Dimensions™ system is designed to provide higher quality 3D™ images for radiologists, a more
comfortable mammography experience for patients and enhanced workflow for technologists.
Discover how sharper images and smarter technologies continue to make it simple to find invasive
cancers – regardless of age or breast density.1-5
R Smart positioning
Quickly move the tube head in
the MLO position for improved
access to the breast.

R
Intelligent 2D™ Field light
Imaging technology option improvements
powered by A.I. Extended field light
Robust, yet natural-looking in biopsy procedures
2D image generated from high enhance the focus on
resolution 3D™ data, delivering the patient.
superior performance at
a low dose compared
to 2D alone.
New stationary
gantry controls
SmartCurve™ breast Improve ergonomics
stabilization system and workflow
Curved compression surface adds to for technologists.
patient comfort and software
maintains image quality.

Clarity HD™ 3D™ imaging

Exclusive detector New grid assembly
technology enables Increase system
high-resolution 3D™ imaging reliability and uptime.
in 3.7 seconds.

3DQuorum™ imaging technology

powered by Genius AI™
Providing the same clinical performance, faster.
Uses AI to uniquely reconstruct high-resolution
3D™ data to produce 6mm SmartSlices. The
SmartSlices are designed to expedite reading
time by reducing the number of images to review,
with no compromise in image quality, sensitivity
or accuracy.
Product information Proof, not promises
The 3Dimensions™ system may be purchased as a 2D or 3D™
configuration. The SmartCurve™ breast stabilization system and
Clarity HD™ high-resolution 3D™ imaging are standard with all
up to 65% 40%
purchases of new 3Dimensions™ systems.
Refer to product datasheet for additional technical product
Reduction
in recalls compared
information. to 2D alone.2-8

Ordering details
Part Number Description

3Dimensions mammography system, 2D configuration, Int’l More invasive breast

3DM-SYS-INTL2D

Over 200
integrating Windows 10
cancers detected,
compared to 2D
3Dimensions mammography system, 2D configuration,
3DM-SYS-INTL2D-MOB mammography Studies demonstrating
mobile ready- Int’l
alone.§ clinical efficacy.
3Dimensions mammography system, 2D configuration,
3DM-SYS-INTL2D-NS
no shield- Int'l

9,000+
3Dimensions mammography system, 3D™ configuration, -
3DM-SYS-INTL3D
Int’l

3Dimensions mammography system, 3D™ configuration,

3DM-SYS-INTL3D-MOB
mobile ready- Int’l

3Dimensions mammography system, 3D™ configuration, no

3DM-SYS-INTL3D-NS
shield- Int’l
Accurate
Only the 3D
Mammography™
exam is FDA
approved as
superior for women Hologic 3D™
with dense breast systems installed
compared to around the world
2D alone.1-2 and counting.
* Data on file (MAN-03608 Rev 006; DHM-05051_002; DHM-06039 Rev 002; MAN-02290 Rev 007)
** When Clarity HD™ high-resolution 3D imaging is used in combination with the optional

45%
Intelligent 2D™ imaging technology license on SecurView® workstations.
§ Results from Friedewald, SM, et al. “Breast cancer screening using tomosynthesis in combination with digital
mammography.” JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000
screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on
screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI:
0.8-1.6) additional invasive breast cancers per 1,000 screening exams were found in women receiving combined 2D Dose reduction with a
FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography™ System versus women receiving 2D generated 2D image.
FFDM mammograms only.

References
1.Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital
mammography. JAMA. 2014 Jun 25;311(24):2499-507. 2.Zuckerman SP, Conant EF, Keller BM, et al. Implementation of
Scan time –
Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. The industry’s fastest
Radiology. 2016 Dec;281(3):730-736. 3.Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis
screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field tomosynthesis scan –
digital mammographic images. Radiology. 2014 Jun;271(3):655-63. 4.Bernardi D, Macaskill P, Pellegrini M, et. al. Breast for reduced chance
cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D
mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13. 5.McDonald
of patient motion
ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: and fewer retakes, as
Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43. 6.Rafferty EA, Durand
MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense
well as reduced
Breasts. JAMA. 2016 Apr 26;315(16):1784-6. 7. Bloomquist AK, Yaffe MJ, Pisano ED et. al. Quality control for digital compression time
mammography in the ACRIN DMIST trial: part I. Med Phys 2006MAN-03608 Revision 006, April 2018

SS-00524-EUR-EN Rev.003 (7/20) Hologic Inc. ©2020 All rights reserved. Hologic, 3D, 3D Mammography, 3Dimensions, 3DQuorum, Clarity HD, Intelligent 2D, SmartCurve, SecurView, The Science
of Sure and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries. This information is intended for medical
professionals and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows,
it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, please contact your local Hologic representative.

www.hologic.com | [email protected] | +32.2.711.4680

No Compromise. No Comparison.